Synthesis, Characterization, Antiproliferative Activity of Galloyl Derivatives and Investigation of Cytotoxic Properties in HepG2/C3A cells

Author:

dos Santos Rafael Claudino1,de Freitas Raquel Oliveira Nascimento2,Foglio Mary Ann3,de Carvalho João Ernesto3,Ruiz Ana Lucia Tasca Góes3,Pessatto Lucas Roberto4,Oliveira Rodrigo Juliano5,Baranoski Adrivanio4,Biazi Bruna Isabela4,Mantovani Mário Sérgio4,Kassuya Candida Aparecida Leite1,de Oliveira Junior Pedro Cruz6,Formagio Anelise Samara Nazari1

Affiliation:

1. Faculty of Health Science, Federal University of Grande Dourados - UFGD, Dourados, Mato Grosso do Sul State, Brazil

2. Industrial chemistry course, State University of Mato Grosso do Sul – UEMS, Dourados, Mato Grosso do Sul State, Brazil

3. Faculty of Pharmaceutical Science, State University of Campinas – UNICAMP, Campinas, São Paulo State, Brazil dBiological Science Center, State University of Londrina – UEL, Londrina, Paraná State, Brazil

4. Graduate Program in Genetics and Molecular Biology, State University of Londrina – UEL, Londrina, Paraná State, Brazil

5. Faculty of Medicine, Federal University of Mato Grosso do Sul – UFMS, Campo Grande, Mato Grosso do Sul State, Brazil

6. Faculty of Biological and Environmental Sciences, Federal University of Grande Dourados - UFGD, Dourados, Mato Grosso do Sul State, Brazil

Abstract

Background: Appropriate substituents in the galloyl group could lead to significant biological properties. Objective: Novel galloyl-substituted compounds bearing 2-substituted-1,3,4-oxadiazol-5-yl, 5-substituted-1,2,4-triazol-3-yl, and carboxamide groups were synthesized and evaluated for their antiproliferative activity. Additionally, galloyl hydrazide (2) was evaluated by performing cytotoxicity, membrane integrity, cell cycle, and apoptosis assays in HepG2/C3A cells. Method: General procedure was used for the synthesis of galloyl-substituted (3-9, 11) and characterized by their spectroscopic data (1H and 13C NMR). The antiproliferative activity of all novel galloyl derivatives was evaluated against nine human tumors and one nontumoral cell line. Three response parameters (GI50, TGI, and LC50) were calculated. The cytotoxicity test was performed for the resazurin assay. The membrane integrity, cell cycle, and apoptosis assays were performed by flow cytometry. Results: The substitution of the methoxy group of the galloyl ring system for a carboxamide group (3, 4, 5, and 6) produced compounds with moderate antitumoral activity, particularly 6, against six human cancer cell lines, K-562, PC-3, NCI-ADR/RES, OVCAR, 786-0 and NCI-H460, with GI50 values ≤ 9.45 µg/mL. Triazole derivatives 7 and 8 exhibited higher antitumoral activity toward OVCAR, MCF-7 and leukemia K-562 cell lines, exhibiting GI50 values less than 10 µg/mL. Compound 11 displayed significant activity against PC-3 (GI50 = 4.31 µg/mL), OVCAR (GI50 = 8.84 µg/mL) and K-562 (GI50 = 8.80 µg/mL) cell lines. Galloyl hydrazide (2) had cytotoxic activity in HepG2/C3A cells (IC50 = 153.7 µg/mL). In membrane permeability, cell count, cell cycle, and apoptosis assays, as determined using the IC50 of compound (2) in HepG2/C3A cells, increased membrane permeability, decreased cell count, altered cell cycle, and initial apoptosis was observed compared to the control group. Conclusion: Thus, our results showed for the first time the synthesis, antiproliferative activity, and cytotoxicity of galloyl-substituted compounds. Galloyl-substitution does not have a very strong synergistic effect in the inhibition of cancer cell proliferation compared with galloyl hydrazide (2). Compound 2 demonstrated promising activity in HepG2/C3A hepatocarcinoma cells.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3